Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Martin Goerner"'
Autor:
Peter Goon, Odile Sauzet, Matthias Schuermann, Felix Oppel, SenYao Shao, Lars-Uwe Scholtz, Holger Sudhoff, Martin Goerner
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract Recurrent Respiratory Papillomatosis(RRP) is a rare disease with severe morbidity. Treatment is surgical. Prevailing viewpoint is that prophylactic HPV vaccines do not have therapeutic benefit due to their modus operandi. Studies on HPV vacc
Externí odkaz:
https://doaj.org/article/05c793da4e45430dadc178f4ab0641f8
Autor:
Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, Jana Schlenzka, Christina Kunz, Marc S. Raab, Jens Hillengaß, Anna Jauch, Anja Seckinger, Dirk Hose, Steffen Luntz, Pieter Sonneveld, Henk Lokhorst, Hans Martin, Martin Goerner, Martin Hoffmann, Hans-Walter Lindemann, Helga Bernhard, Igor W. Blau, Christof Scheid, Britta Besemer, Katja C. Weisel, Mathias Hänel, Jan Dürig, Hartmut Goldschmidt, German-Speaking Myeloma Multicenter Group (GMMG)
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Lenalidomide (LEN) maintenance (MT) post autologous stem cell transplantation (ASCT) is standard of care in newly diagnosed multiple myeloma (MM) but has not been compared to other agents in clinical trials. We retrospectively compared borte
Externí odkaz:
https://doaj.org/article/c1262202ec704fb3bc2b8009125681e4
Autor:
Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Marc S. Raab, Igor W. Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, on behalf of the German-Speaking Myeloma Multicenter Group (GMMG)
Publikováno v:
Cancers, Vol 13, Iss 19, p 4856 (2021)
We investigated the prognostic impact of time-dependent serum free light chain ratio (FLCr) normalization in 590 patients with secretory multiple myeloma (MM) during first-line treatment within the German-Speaking Myeloma Multicenter Group MM5 trial.
Externí odkaz:
https://doaj.org/article/2bd4474252bd46afbfd0c00fb6855c0f
Autor:
Katja Weisel, Britta Besemer, Mathias Haenel, Raphael Lutz, Christoph Mann, Markus Munder, Martin Goerner, Hans Christian Reinhardt, Axel Nogai, Yon-Dschun Ko, Maike De Wit, Hans Salwender, Christoph Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Anna Jauch, Manola Zago, Axel Benner, Diana Tichy, Carsten Bokemeyer, Hartmut Goldschmidt, Lisa B. Leypoldt
Publikováno v:
Blood. 140:1836-1838
Autor:
Peter Goon, Odile Sauzet, Matthias Schuermann, Felix Oppel, SenYao Shao, Lars-Uwe Scholtz, Holger Sudhoff, Martin Goerner
Objectives and importance:Recurrent Respiratory Papillomatosis(RRP) is a rare disease with severe morbidity. Treatment is surgical. Prevailing viewpoint is that prophylactic HPV vaccines do not have therapeutic benefit due to their modus operandi. St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f27774ea13aa2e487bdf5a11c9870d2
https://doi.org/10.21203/rs.3.rs-1744765/v1
https://doi.org/10.21203/rs.3.rs-1744765/v1
Autor:
Maher Hanoun, Leo Ruhnke, Michael Kramer, Christine Hanoun, Kerstin Schäfer-Eckart, Björn Steffen, Tim Sauer, Stefan Krause, Christoph Schliemann, Jan-Henrik Mikesch, Martin Kaufmann, Mathias Haenel, Edgar Jost, Tim Bruemmendorf, LArs Fransecky, Sabrina Kraus, Hermann Einsele, Dirk Niemann, Andreas Neubauer, Johannes Kullmer, Ruth Seggewiss-Bernhard, Martin Goerner, Gerhard Held, Ulrich Kaiser, Sebastian Scholl, Andreas Hochhaus, Hans Reinhardt, Uwe Platzbecker, Claudia Baldus, Carsten Müller-Tidow, Martin Bornhäuser, Hubert Serve, Christoph Röllig
Higher doses of cytarabine appear to improve long-term outcome in acute myeloid leukemia (AML), in particular for younger patients. To this end, the optimal dosage of single agent cytarabine in consolidation therapy remains elusive. Here, we assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3efddf187af967c6dd3436ccf5d34d1
https://doi.org/10.21203/rs.3.rs-1704919/v1
https://doi.org/10.21203/rs.3.rs-1704919/v1
Head and neck cancers are unique in so far that 2 major oncogenic viruses, EBV and HPV infect adjacent anatomy and cause nasopharyngeal and oropharyngeal cancers respectively. Dominant recognised carcinogens are alcohol and tobacco but some head and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059270530dfaf6815dc2fd599b79ee1c
https://doi.org/10.1002/jmv.28254
https://doi.org/10.1002/jmv.28254
Autor:
Stephan Fuhrmann, Peter Brossart, Markus Munder, Mathias Hänel, Anja Seckinger, Katja Weisel, Hartmut Goldschmidt, Helga Bernhard, Jan Dürig, Anna Jauch, Martin Goerner, Christina Kunz, Hans-Walter Lindemann, Steffen Luntz, Ahmet H. Elmaagacli, Igor Wolfgang Blau, Hans Salwender, Maximilian Merz, Sandra Sauer, Marc S. Raab, Martin Hoffmann, Elias K. Mai, Kaya Miah, Axel Benner, Dirk Hose, Uta Bertsch, Christof Scheid
Publikováno v:
Leukemia
Intensive upfront therapy in newly-diagnosed multiple myeloma (MM) including induction therapy (IT), high-dose melphalan (MEL200), and autologous blood stem cell transplantation (ASCT) followed by consolidation and/or maintenance is mostly restricted
Autor:
Martin Goerner, Markus Munder, Martin Hoffmann, Katja Weisel, Peter Brossart, Elias K. Mai, Anja Seckinger, Hans Salwender, Bernhard Rabold, Dirk Hose, Thomas Hielscher, Igor Wolfgang Blau, Uta Bertsch, Steffen Luntz, Ahmet H. Elmaagacli, Stefanie Huhn, Nicola Giesen, Hartmut Goldschmidt, Jens Hillengass, Marc S. Raab, Christina Kunz, Christof Scheid, Anna Jauch, Maximilian Merz, Diana Tichy, Barbara Hügle-Dörr, Hans-Walter Lindemann, Mathias Hänel, Helga Bernhard, Jan Dürig, Stephan Fuhrmann
Publikováno v:
Leukemia. 34:1853-1865
The MM5 trial aimed at demonstrating a progression-free survival (PFS) difference in continued vs. response-adapted (in case of complete response, CR) lenalidomide (LEN) maintenance therapy (MT) in newly diagnosed, transplant-eligible multiple myelom
Autor:
Axel Benner, Stephan Fuhrmann, Igor Wolfgang Blau, Martin Goerner, Uta Bertsch, Steffen Luntz, Markus Munder, Elias K. Mai, Katja Weisel, Ahmet H. Elmaagacli, Maximilian Merz, Sandra Sauer, Marc S. Raab, Hartmut Goldschmidt, Kaya Miah, Hans Salwender, Mathias Hänel, Christina Kunz, Anna Jauch, Jan Dürig, Christof Scheid, Anja Seckinger, Dirk Hose, Hans-Walter Lindemann, Peter Brossart, Helga Bernhard, Martin Hoffmann
The article Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age, written by Elias K. Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Markus Munder, H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683fb2bdb48b3c1b3cb39211af9e1813
https://hdl.handle.net/20.500.14017/d95b8682-3f21-444c-a851-40ea53cb6c03
https://hdl.handle.net/20.500.14017/d95b8682-3f21-444c-a851-40ea53cb6c03